iTonic (ITOC) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iTonic is the larger company by market cap ($29.0 million vs $3.1 million), about 9.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITOC | NXL |
|---|---|---|
| Share price | $3.97 | $3.68 |
| Market cap | $29.04M | $3.05M |
| 1-day change | -1.25% | -10.46% |
| YTD return | -40.32% | — |
| 1-year return | -64.16% | — |
| EPS (TTM) | $-4.22 | $-14.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $50.70 |
| 52-week low | $3.42 | $3.50 |
| Distance from 52-week high | -78.42% | -92.74% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +307.61% |
| Average volume | 50.95K | 1.02M |
| Shares outstanding | 6.84M | 829.40K |
| Employees | 7 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- iTonic is about 9.5 times larger than Nexalin Technology by market value ($29.04M vs $3.05M).
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
ITOC vs NXL FAQ
Which is bigger, iTonic or Nexalin Technology?
iTonic (ITOC) is larger, with a market capitalization of $29.04M compared with $3.05M for Nexalin Technology (NXL).
Are iTonic and Nexalin Technology in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.